Literature DB >> 7835448

Posterior capsule opacification following diabetic extracapsular cataract extraction.

A Ionides1, J G Dowler, P G Hykin, P H Rosen, A M Hamilton.   

Abstract

Review was performed of extracapsular cataract extraction with posterior chamber lens implantation in 90 diabetic patients and 263 non-diabetic patients. There was a higher incidence of posterior capsular opacification as judged by the requirement for Nd:YAG posterior capsulotomy in patients with non-proliferative (12/35, 34%) or quiescent proliferative diabetic retinopathy (8/18, 44%) than in non-diabetic patients (48/263, 18%) (Mantel-Haenszel p = 0.04). Although subgroup analysis showed a higher incidence of posterior capsule opacification in diabetics with non-proliferative or quiescent proliferative retinopathy than in diabetics without retinopathy, this was not statistically significant (Mantel-Haenszel p = 0.19 and p = 0.07, respectively). Following cataract surgery in diabetics with retinopathy, frequent review and prompt management of posterior capsular opacification is recommended, to maintain adequate fundus visualisation at a time when deterioration of retinopathy is likely.

Entities:  

Mesh:

Year:  1994        PMID: 7835448     DOI: 10.1038/eye.1994.132

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  10 in total

1.  Nd:YAG capsulotomy rates after use of the AcrySof acrylic three piece and one piece intraocular lenses.

Authors:  S I Mian; K Fahim; A Marcovitch; H Gada; D C Musch; A Sugar
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

2.  Pseudoexfoliation syndrome and secondary cataract.

Authors:  M Küchle; A Amberg; P Martus; N X Nguyen; G O Naumann
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

3.  Progression of diabetic retinopathy following cataract surgery: can it be prevented?

Authors:  D W Flanagan
Journal:  Br J Ophthalmol       Date:  1996-09       Impact factor: 4.638

4.  A prospective evaluation of posterior capsule opacification in eyes with diabetes mellitus: a case-control study.

Authors:  M R Praveen; A R Vasavada; G D Shah; A R Shah; B M Khamar; K H Dave
Journal:  Eye (Lond)       Date:  2014-03-28       Impact factor: 3.775

5.  The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract.

Authors:  Maged S Habib; Paul S Cannon; David H W Steel
Journal:  BMC Ophthalmol       Date:  2005-06-22       Impact factor: 2.209

6.  In vitro growth of lens epithelial cells from cataract patients - association with possible risk factors for posterior capsule opacification.

Authors:  Karin Sundelin; Anne Petersen; Yalda Soltanpour; Madeleine Zetterberg
Journal:  Open Ophthalmol J       Date:  2014-05-30

7.  The Role of Optical Coherence Tomography Signal Strength in the Diagnosis and Follow-up of Patients with Posterior Capsular Opacification Treated with Nd:YAG Laser Capsulotomy

Authors:  Mustafa Vatansever; Erdem Dinç; Özer Dursun; Ufuk Adıgüzel; Ayça Yılmaz; Gülhan Ö. Temel
Journal:  Turk J Ophthalmol       Date:  2020-03-05

8.  Apoptosis of lens epithelial cells induced by high concentration of glucose is associated with a decrease in caveolin-1 levels.

Authors:  Zhiyong Zhang; Ke Yao; Chongfei Jin
Journal:  Mol Vis       Date:  2009-09-30       Impact factor: 2.367

9.  Advanced glycation end products in human diabetic lens capsules.

Authors:  Johanna Rankenberg; Stefan Rakete; Brandie D Wagner; Jennifer L Patnaik; Christian Henning; Anne Lynch; Marcus A Glomb; Ram H Nagaraj
Journal:  Exp Eye Res       Date:  2021-07-21       Impact factor: 3.770

10.  Neodymium:yttrium-aluminum garnet capsulotomy rates after combined cataract surgery with implantation of a 4% water content hydrophobic acrylic intraocular lens and vitrectomy.

Authors:  Yoshiaki Kabata; Genichiro Takahashi; Hiroshi Tsuneoka
Journal:  Clin Ophthalmol       Date:  2013-11-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.